Single-Cell Proteomics Preparation for Mass Spectrometry Analysis Using Freeze-Heat Lysis and an Isobaric Carrier
December 9th, 2022
4K views
In this protocol, we describe how to prepare mammalian cells for single-cell proteomics analysis via mass spectrometry using commercially available reagents and equipment, with options for both manual and automatic pipetting.
Overview
This protocol outlines the preparation of mammalian cells for single-cell proteomics analysis using mass spectrometry. By employing the SCoPE2 approach, it enables researchers to quantify thousands of proteins from individual cells, revealing proteome heterogeneity that is typically obscured in bulk analyses.
Key Study Components
Research Area
- Single-cell proteomics
- Cancer research
- Immunology
Background
- Proteome heterogeneity and its significance
- Accessibility of mass spectrometry techniques
- Importance of analyzing single cells for biological insights
Methods Used
- Cell lysis procedure using a thermal cycler and sonication
- Use of a 384-well plate for sample preparation
- Tandem mass tagging for quantifying proteins without antibodies
Main Results
- Successful quantification of thousands of proteins from thousands of single cells
- Demonstrated differential protein abundance among single cells in the same population
- Estimation of digestion and labeling efficiency using DO-MS software
Conclusions
- The SCoPE2 protocol simplifies single-cell proteomics, making it accessible worldwide
- This method enhances our understanding of cellular diversity and protein expression
Frequently Asked Questions
What is SCoPE2?
SCoPE2 is a method for performing single-cell proteomics analysis that quantifies proteins from thousands of cells without the need for antibodies.
How does this protocol help in cancer research?
By providing insights into protein abundance variations among single cells, the protocol can help identify biomarkers and therapeutic targets in cancer.
What equipment is needed for this protocol?
The protocol can be conducted with basic lab equipment like pipettes, or more advanced liquid handling robotics.
How long does the sample preparation take?
The entire process can vary, but it typically involves multiple steps that accumulate over several hours of incubation and processing.
Is this method suitable for high-throughput analysis?
Yes, the protocol is designed to accommodate both manual and automated high-throughput sample processing.
What types of samples can be used with this method?
Mammalian cells can be used for this protocol, making it applicable to various biological studies.
How do I ensure high recovery of peptides during preparation?
Careful liquid handling and following the protocol closely are crucial for maximizing peptide recovery.
Executive Industry Relevance
Single-cell proteomics using the SCoPE2 protocol enables high-resolution quantification of protein heterogeneity across thousands of individual mammalian cells, addressing a critical gap in early discovery and target validation. By leveraging freeze-heat lysis and isobaric carrier strategies, this workflow supports robust, scalable, and accessible proteomic profiling for diverse R&D teams. The approach enhances predictive confidence at key inflection points in the discovery pipeline, facilitating risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of proteome heterogeneity at the single-cell level for mechanistic de-risking.
- Supports functional target validation by quantifying differential protein abundance within cell populations.
- Facilitates predictive confidence in pathway analysis and biological triage.
Screening & Assay Development
- Prepares validated single-cell samples for downstream LC-MS/MS workflows using standardized protocols.
- Delivers quantitative, reproducible protein measurements suitable for high-throughput screening.
- Enables assay scalability and platform reuse through automation compatibility and accessible reagents.
Translational & Preclinical Research
- Aligns with disease-relevant systems by supporting proteomic profiling in cancer and immunology research.
- Provides continuity from discovery to preclinical validation by enabling robust biomarker and pathway analysis.
- Reduces translational risk by revealing cellular diversity not captured in bulk analyses.
Pipeline & Workflow Integration
The SCoPE2 protocol integrates from early discovery through lead identification, supporting both manual and automated workflows for single-cell proteomics.
- Discovery Biology: Advances hypothesis testing and pathway clarification by quantifying protein expression at single-cell resolution.
- Screening: Delivers reproducible, quantitative outputs for reliable compound evaluation and assay development.
- Analytics: Provides statistical outputs, including digestion and labeling efficiency, to compare experimental conditions.
- Translational Research: Supports biomarker alignment and disease model validation in preclinical studies.
- Enterprise Reuse: Offers a scalable, accessible protocol adaptable across research teams and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes sample preparation and enables reproducibility across manual and automated platforms.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by providing robust single-cell data.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery programs.
Implementation Considerations
- Requires expertise in single-cell handling, mass spectrometry, and quantitative proteomics.
- Needs access to LC-MS/MS instrumentation and liquid handling infrastructure.
- Demands rigorous cross-team standardization for sample preparation and data analysis.
- Adaptable to both manual and automated workflows, supporting diverse research environments.
- Sample loss and data completeness must be monitored using quality control metrics and software tools.
Biopharma FAQs
Why does null hypothesis testing matter for SCoPE2 target validation?
Null hypothesis testing in SCoPE2 enables objective assessment of protein abundance differences between single cells, supporting robust target validation. This statistical rigor helps distinguish true biological variation from technical noise, increasing confidence in early discovery decisions.
How does independent variable isolation fit SCoPE2 discovery workflows?
Isolating single cells and controlling experimental variables in SCoPE2 allows precise attribution of proteomic changes to specific biological or treatment conditions. This isolation is essential for mechanistic de-risking and accurate interpretation of cellular heterogeneity.
What do quantitative dependent variable measurements enable in SCoPE2?
Quantitative measurement of protein abundance per cell enables high-resolution mapping of proteome diversity, facilitating pathway analysis and functional target validation. These outputs support data-driven prioritization in screening and translational research.
Why are replication requirements critical for SCoPE2 cross-functional teams?
Replication in SCoPE2 ensures reproducibility and reliability of single-cell proteomics data, which is vital for cross-functional collaboration and downstream decision-making. Consistent results across replicates build trust in the workflow and its outputs.
What statistical analysis capabilities are needed before SCoPE2 implementation?
Effective SCoPE2 deployment requires statistical tools for assessing digestion and labeling efficiency, missing data rates, and differential protein abundance. These analyses underpin quality control and inform go/no-go decisions in the discovery pipeline.
